Evidence map›Paper›PMID 35951110›Full record

ArticleCellular and molecular life sciences : CMLS2022

Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells.

Lisa Epping, Christina B Schroeter, Christopher Nelke, Stefanie Bock, Lukas Gola, Nadine Ritter, Alexander M Herrmann, Saskia Räuber, Antonia Henes, Beatrice Wasser and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. EndothelialThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Lisa Epping *Department of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
Christina B Schroeter *Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-1391-7817
Christopher Nelke *Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Stefanie BockDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Lukas GolaDepartment of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
Nadine RitterDepartment of Cardiovascular Medicine, Institute for Cellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.
Alexander M HerrmannDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Saskia RäuberDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Antonia HenesDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Beatrice WasserDepartment of Neurology, University Medical Center Mainz, Mainz, Germany.
Juncal Fernandez-OrthDepartment of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
Winfried NeuhausCompetence Unit Molecular Diagnostics, AIT - Austrian Institute of Technology GmbH, Vienna, Austria.
Stefan BittnerDepartment of Neurology, University Medical Center Mainz, Mainz, Germany.
Thomas BuddeInstitute of Physiology I, University of Münster, Münster, Germany.
Michael PlattenDKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Stjepana KovacDepartment of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
Guiscard SeebohmDepartment of Cardiovascular Medicine, Institute for Cellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.
Tobias RuckDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Manuela Cerina *Department of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.
Sven G Meuth *Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. meuth@uni-duesseldorf.de.
Heinrich Heine University Düsseldorf · DEUniversity Hospital Münster · DEJohannes Gutenberg University Mainz · DEAustrian Institute of Technology · ATGerman Cancer Research Center · DEUniversity of Münster · DE

Funding

Deutsche Forschungsgemeinschaft 39404578Deutsche Forschungsgemeinschaft ME 3283/6-1
6 · The paper itself

Abstract

Blood-brain barrier (BBB) integrity is necessary to maintain homeostasis of the central nervous system (CNS). NMDA receptor (NMDAR) function and expression have been implicated in BBB integrity. However, as evidenced in neuroinflammatory conditions, BBB disruption contributes to immune cell infiltration and propagation of inflammatory pathways. Currently, our understanding of the pathophysiological role of NMDAR signaling on endothelial cells remains incomplete. Thus, we investigated NMDAR function on primary mouse brain microvascular endothelial cells (MBMECs). We detected glycine-responsive NMDAR channels, composed of functional GluN1, GluN2A and GluN3A subunits. Importantly, application of glycine alone, but not glutamate, was sufficient to induce NMDAR-mediated currents and an increase in intracellular Ca

Indexed as

GlycineReceptors, N-Methyl-D-AspartateAnimalsBlood-Brain BarrierEndothelial CellsMiceN-MethylaspartateReceptors, GlycineGluN3A protein, mouseGlycineN-MethylaspartateReceptors, GlycineReceptors, N-Methyl-D-AspartateBlood–brain barrierCa2+ signalingGlutamateGlycineMBMECNMDAR

Identifiers

PMID35951110
PMCPMC9372018
OpenAlexW4291396229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.